Cargando…

Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction

BACKGROUND: The survival benefit associated with cumulative adherence to multiple clinical and lifestyle‐related guideline recommendations for secondary prevention after acute myocardial infarction (AMI) is not well established. METHODS AND RESULTS: We examined adults with AMI (mean age 68 years; 64...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solomon, Matthew D., Leong, Thomas K., Levin, Eleanor, Rana, Jamal S., Jaffe, Marc G., Sidney, Stephen, Sung, Sue Hee, Lee, Catherine, DeMaria, Anthony, Go, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335507/ https://www.ncbi.nlm.nih.gov/pubmed/32131689 http://dx.doi.org/10.1161/JAHA.119.014415

Ejemplares similares

Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome
por: Ergatoudes, Constantinos, et al.
Publicado: (2016)

Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000–2015
por: Sidney, Stephen, et al.
Publicado: (2017)

Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
por: Jortveit, Jarle, et al.
Publicado: (2022)

Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
por: Halvorsen, Sigrun, et al.
Publicado: (2016)

Management of patients with acute ST-segment elevation myocardial infarction in Russian hospitals adheres to international guidelines
por: Kontsevaya, Anna V, et al.
Publicado: (2020)

Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction
por: Lee, Seung-Hwa, et al.
Publicado: (2023)

Contemporary Reevaluation of Race and Ethnicity With Outcomes in Heart Failure
por: Savitz, Samuel T., et al.
Publicado: (2021)

Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction
por: Arnold, Suzanne V., et al.
Publicado: (2020)

Guidelines for experimental models of myocardial ischemia and infarction
por: Lindsey, Merry L., et al.
Publicado: (2018)

Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population
por: Zhang, Yijun, et al.
Publicado: (2023)

Self‐Controlled Case‐Series Study to Verify the Effect of Adherence to Beta‐Blockers in Secondary Prevention of Myocardial Infarction
por: Di Bartolomeo, Stefano, et al.
Publicado: (2015)

Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction
por: Adamek, Kylie E., et al.
Publicado: (2019)

Biomarkers in acute myocardial infarction
por: Chan, Daniel, et al.
Publicado: (2010)

Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction
por: Schroeder, Mary C., et al.
Publicado: (2022)

Repetitive Myocardial Infarctions Secondary to Delirium Tremens
por: Schwartzberg, David, et al.
Publicado: (2014)

Acute Myocardial Infarction Secondary to Paradoxical Embolism
por: Alenezi, Abdullah R, et al.
Publicado: (2020)

Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction
por: Song, Pil Sang, et al.
Publicado: (2018)

Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction
por: Kosobucka, Agata, et al.
Publicado: (2018)

The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation
por: Naser, Nabil, et al.
Publicado: (2017)

Diagnosing Medication Non-Adherence in a Patient with Myocardial Infarction
por: Ye, Siqin, et al.
Publicado: (2012)

Medication adherence and its determinants in patients after myocardial infarction
por: Pietrzykowski, Łukasz, et al.
Publicado: (2020)

Effect of implementing an acute myocardial infarction guideline on quality indicators
por: Makdisse, Marcia, et al.
Publicado: (2013)

Cumulative Serum Uric Acid and Its Time Course Are Associated With Risk of Myocardial Infarction and All‐Cause Mortality
por: Tian, Xue, et al.
Publicado: (2021)

The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction
por: Di Martino, Mirko, et al.
Publicado: (2015)

Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
por: Kirsch, Florian, et al.
Publicado: (2020)

Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer
por: Noyd, David H., et al.
Publicado: (2021)

Long‐Term Risk Stratification of Patients Undergoing Coronary Angiography According to the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention
por: Zafrir, Barak, et al.
Publicado: (2019)

Patient Adherence to Therapy After Myocardial Infarction: A Scoping Review
por: Zorina, Olga, et al.
Publicado: (2022)

Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
por: Birnbaum, Yochai, et al.
Publicado: (2020)

Guideline adherence in the use of coronary angiography in patients presenting at the emergency department without myocardial infarction – Results from the German ENLIGHT-KHK project()
por: Wein, Bastian, et al.
Publicado: (2023)

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) SECONDARY TO INTRACORONARY THROMBOSIS (ICT) IN AN ASYMPTOMATIC COVID-19 POSITIVE PATIENT
por: Anthony, Jamal A., et al.
Publicado: (2023)

Secondary Prevention of Myocardial Infarction in People Living With HIV Infection
por: Erqou, Sebhat, et al.
Publicado: (2020)

Acute myocardial infarction secondary to mucormycosis after lung transplantation
por: Naik, Chetan A., et al.
Publicado: (2020)

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION SECONDARY TO COVID-19
por: DOUEDI, STEVEN, et al.
Publicado: (2021)

Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors
por: Sundbøll, Jens, et al.
Publicado: (2022)

Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018
por: Lõiveke, Piret, et al.
Publicado: (2021)

Correlation of cumulative ST elevation with left ventricular ejection fraction and 30-day outcome in patients with ST elevation myocardial infarction
por: Kiron, V, et al.
Publicado: (2019)

Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction
por: Campain, Anna, et al.
Publicado: (2022)

Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients
por: Hawkes, Anna L, et al.
Publicado: (2009)

Use of Guideline-Directed Medical Therapy in Patients With ST-Elevation Myocardial Infarction
por: Latifi, Ahmad Nawid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1j5h3mont1r19sb3cvpm5ers82